InterCure (INCR)
Produces and distributes pharmaceutical-grade medical cannabis through an integrated Israeli platform.
Something off on this page? Send us feedback.
Produces, processes, exports, and distributes pharmaceutical-grade medical cannabis through Canndoc, alongside pharmacy retail operations. The business combines production and branded products with distribution partnerships and retail pharmacies in Israel and Germany.
Medical-cannabis operations run mainly through wholly owned Canndoc, Pharmazone, and Cannolam. Canndoc produces, processes, exports, and distributes pharmaceutical-grade medical cannabis, while Kan Olam, Givol, and Leon Pharm operate retail pharmacies.
The platform combines production, research and development, distribution partnerships, branded products, and pharmacy retail. Its principal operations are in Israel, with current materials also describing operations in Germany.
Production, importation, and sales at the Nir Oz facility resumed during 2025 after the October 7 disruption, while genetic-bank recovery remained an active focus. The ordinary shares remain listed and traded during Nasdaq's initial minimum-bid-price compliance period.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Dec 31, 2025Cash & short-term investments $15.5M · Total debt $60.7M · Total assets $229.1M · Shareholders' equity $131.5M
- Revenue
- $23.3M
- Operating income
- −$5.5M
- Net income
- −$5.6M
Reported in ILS, converted at the latest exchange rate
No dividends on record.
| Institutions | 1.03% | 122.3K shares | |
|---|---|---|---|
| 15 holders · as of Jun 30, 2026 | |||
| Insiders | 21.03% | 2.49M shares | |
| 3 holders · as of Apr 20, 2026 | |||
| Other | 77.94% | 9.23M shares | |
| remainder | |||
11.85M company shares as of Aug 25, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Alexander RabinovichInsiderdirector, officer: Chief Executive Officer | 20.88% | 2.47M | filed Apr 20, 2026 |
Healthcare of Ontario Pension Plan Trust FundInstitution | 0.36% | 212,500 | as of Jun 30, 2026 |
Citadel Advisors LLCInstitution | 0.18% | 107,913 | as of Jun 30, 2026 |
Moore Capital Management, LPInstitution | 0.16% | 97,273 | as of Jun 30, 2026 |
Amos CohenInsiderofficer: Chief Financial Officer | 0.13% | 15,989 | filed Apr 16, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- Cronos Group
PEACE NATURALS flower competes for Israeli medical-cannabis patients
- IM Cannabis
Israeli import, distribution, pharmacy, and online medical-cannabis platform
- Village Farms International
EU-GMP Canadian medical-cannabis exports supply the Israeli market
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| InterCure | $5.35 | +2.00% | $62.1M | — | — | — | — |
| Cronos Group | $3.37 | +1.05% | $1.24B | 18.4 | 56.1 | 5.1 | +58.4% |
| IM Cannabis | $4.57 | +48.14% | $1.9M | — | — | 0.1 | −42.1% |
| Village Farms International | $3.09 | +7.29% | $350.8M | 15.3 | 15.6 | 1.5 | +6.8% |
| Median | 16.9 | 35.8 | 1.5 | +6.8% |